Yunnan Energy International Co. Limited 雲 能 國 際 股 份 有 限 公 司 * （ 於 百慕 達 註 冊 成 立 之 有 限 公 司） （香港股份代號：1298） （新加坡股份代號：T43） 董事名單及其角色與職能 雲能國際股份有限公司董事會成員載列如下： 執行董事 祝映雪女士 宋赫男先生 楊傑先生 王金先生 獨立非執行董事 施法振先生 劉宗柳先生 景丕林女士 董事會轄下設有三個委員會。下表載列有關委員會的成員資訊： | | 董事會委員會 | | | | --- | --- | --- | --- | | 董事 | 審核委員會 | 薪酬委員會 | 提名委員會 | | 祝映雪女士 | | M | C | | 宋赫男先生 | | M | M | | 楊傑先生 | | | | | 王金先生 | | | | | 施法振先生 | C | C | M | | 劉宗柳先生 | M | M | M | | 景丕林女士 | M | M | M | 附注： C 有關董事委員會之主席 M 有關董事委員會之成員 香港，2025年8月1日 * 僅供識別 ...

香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所有限公司對 本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對 因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 Yunnan Energy International Co. Limited （ 於 百慕 達 註 冊 成 立 之 有 限 公 司） 雲 能 國 際 股 份 有 限 公 司 * （香港股份代號：1298） （新加坡股份代號：T43） 本公告由雲能國際股份有限公司（「本公司」，連同其附屬公司統稱為「本集團」）董事（「董 事」）會（「董事會」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.51(2)條 作出。 董事會欣然宣佈，執行董事宋赫男先生（「宋先生」）已獲委任為本公司行政總裁、薪酬委 員會成員及提名委員會成員，由2025年8月1日起生效。宋先生的履歷詳情載列如下： 宋先生，33歲，於2021年7月28日獲委任為執行董事。宋先生於2017年8月加入雲南省能源 投資集團有限公司。彼曾任香港雲能國際投資有限公司金融投資部高級投資經理及資本 管理部（金融投資部）副部 ...

致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 公司名稱: 雲能國際股份有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01298 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 800,000,000 | USD | | 0.05 | USD | | 40,000,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 800,000,000 | USD | | 0.05 | USD | | 40,000,000 | 本月底法定/註冊股本 ...

Group 1 - The core viewpoint of the news highlights the significant stock performance of Yuneng International, which saw a 75.71% increase in share price, despite a year-to-date decline of 29.29% [1] - As of December 31, 2024, Yuneng International reported total revenue of 534 million yuan, representing a year-on-year growth of 68.67%, and a net profit attributable to shareholders of 454,700 yuan, with a growth of 109.88% [1] - The company's gross profit margin stands at 5.18%, and its debt-to-asset ratio is 60.43% [1] Group 2 - Currently, there are no institutional investment ratings for Yuneng International [2] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -3.39 times, with a median of 1.17 times, while Yuneng International's P/E ratio is significantly higher at 392.68 times, ranking 53rd in the industry [2] - Yuneng International is a Bermuda-registered investment holding company, primarily engaged in the distribution and after-sales service of various analytical instruments in China, including chromatography, spectrometers, and electron microscopes [2]

Core Viewpoint - The article highlights various high-paying job opportunities in the scientific instrument sector, emphasizing the demand for skilled sales and technical support professionals in this industry [2][14][20]. Group 1: Sales Positions - Agilent Technologies (China) is hiring a Channel Sales Manager in Beijing with a salary range of 18k-28k, requiring 3-5 years of channel management experience [2]. - OsiSense (Beijing) is looking for a Key Account Sales Manager with a salary range of 20k-30k, requiring experience in B2B large project sales [3]. - Shanghai Kezhe Biochemical Technology is seeking an Automation Project Sales Manager in Shanghai with a salary range of 13k-22k, requiring over 3 years of relevant experience [4]. Group 2: Technical Support and After-Sales Positions - Labtech is hiring a Mass Spectrometry Maintenance Engineer in Guangzhou with a salary range of 10k-12k, requiring at least 1 year of experience with ICPMS [14]. - Shanghai Linli Instrument Co. is looking for an Inorganic Analysis After-Sales Engineer with a salary range of 10k-30k, requiring over 2 years of relevant experience [16]. - Beijing Jingwei Gaobo Instrument Co. is seeking a Technical Support Engineer in Beijing with a salary range of 8k-20k, requiring a background in chemistry or materials [17]. Group 3: Regional Sales Positions - Liaoning Jiahua International Trade is hiring an Instrument Sales Engineer for the Panjin region, requiring at least 2 years of chromatography and spectroscopy sales experience [7]. - DCH Science Instrument Department is looking for a Regional Sales Manager in Beijing, requiring over 3 years of sales experience in materials science or chemical analysis [8]. - Hangzhou Puyue Technology Development is seeking a Regional Sales Manager for laboratories in Chengdu with a salary range of 8k-15k, requiring knowledge of chromatography/spectroscopy [10][11].

Core Viewpoint - Yuneng International (01298) reported a significant increase in revenue for the fiscal year 2024, achieving a total revenue of HKD 571 million, representing a year-on-year growth of 65.64% and turning a profit with a net profit of HKD 491,000 [3] Financial Performance - The company’s operating cash flow was negative at HKD -75.77 million, a decrease of HKD 89.77 million compared to the previous year [30] - Basic earnings per share were HKD 0.0018, with a weighted average return on equity of 0.3%, an increase of 3.25 percentage points year-on-year [26] - The price-to-earnings ratio (TTM) is approximately 392.68, with a price-to-book ratio of 1.17 and a price-to-sales ratio of 0.33 as of April 29 [3] Revenue Composition - For 2024, the revenue composition was HKD 524.5 million from the supply chain business and HKD 52.1 million from the distribution business [21] - In 2023, the revenue from the supply chain business was HKD 284.6 million, indicating growth in this segment [23] Asset and Liability Changes - As of the end of 2024, cash and cash equivalents decreased by 45.23%, while accounts receivable increased by 52.21% and inventory rose by 78.27% [38] - Short-term borrowings increased by 68.13%, and accounts payable rose by 86.26%, indicating a significant rise in liabilities [41] - The current ratio was reported at 1.49, and the quick ratio was 1.2 [45]

Financial Performance - The company achieved a revenue of approximately HKD 576.6 million in 2024, representing a 68.7% increase from HKD 341.9 million in 2023[6]. - The company recorded a net profit of HKD 0.5 million in 2024, reversing a loss of approximately HKD 5 million in 2023, primarily due to increased revenue and gross profit from the supply chain business[6]. - The company's supply chain business revenue increased by HKD 239.9 million or 84.3% to HKD 524.5 million in fiscal year 2024, driven by higher demand for agricultural and industrial products[19]. - Total revenue for fiscal year 2024 rose by HKD 234.7 million or 68.7% to HKD 576.6 million, primarily due to the significant contribution from the supply chain business[20]. - Gross profit for fiscal year 2024 increased by 196.5% to HKD 29.9 million, with a gross margin of 5.2%, up 2.2 percentage points from 3.0% in fiscal year 2023[22]. - The company reported a profit attributable to equity holders of HKD 491,000 for 2024, a recovery from a loss of HKD 4,970,000 in 2023[176]. - The basic and diluted earnings per share for 2024 were HKD 0.18, recovering from a loss per share of HKD 1.80 in 2023[176]. Business Strategy and Expansion - The company plans to further expand its market in Southwest China and actively participate in public tenders for medical equipment in 2025[8]. - The supply chain business will focus on long-term supply agreements for coal, traditional Chinese medicine products, and photovoltaic components, while exploring the export of new energy vehicles[8]. - The company successfully invested in a green energy project in Dayao, Yunnan, laying a solid foundation for future expansion into the Southeast Asian green energy market[7]. - The group plans to expand its distribution business in Southwest China, aiming for increased sales contracts in 2025, leveraging established relationships with well-known brands[38]. - The group aims to sign long-term supply agreements in the coal and traditional Chinese medicine sectors, while also expanding international trade in photovoltaic projects and electrolytic copper[40]. - The group is actively exploring green energy project investments in Yunnan and Southeast Asia, aiming to increase installed capacity and enhance revenue contributions[41]. - In 2025, the group will deepen its market presence in Southeast Asia, focusing on green energy projects in Laos and Myanmar[43]. Operational Efficiency and Management - The company aims to optimize resource allocation and enhance operational efficiency in its green energy business to achieve scalable development and sustainable long-term returns for shareholders[9]. - The company is leveraging its 30 years of customer base and management experience in the international supply chain to expand its market share[7]. - The company will continue to cautiously manage its distribution and supply chain businesses while accelerating international energy project investments[8]. - The management team for the supply chain business consists of 11 experienced members, led by a professional with over 20 years of international trade experience[40]. - The group plans to expand its business team in the next 12 months to meet growing market demands[40]. - The company aims to improve operational efficiency and alleviate current market challenges by utilizing existing resource advantages[45]. Corporate Governance - The company has established corporate governance practices in line with the Hong Kong Stock Exchange's guidelines, ensuring compliance for the fiscal year ending December 31, 2024[56]. - The board consists of eight directors, including five executive directors and three independent non-executive directors[60]. - The independent non-executive directors are Liu Zongliu, Jing Pilin, and Shi Fazhen, who continue to meet the independence criteria as per listing rules[62]. - The board is responsible for major investments, corporate restructuring, mergers and acquisitions, and the announcement of financial performance[58]. - The company aims to maintain high levels of corporate governance to enhance shareholder value[56]. - The board's independent non-executive director has over 17 years of experience in auditing and accounting, ensuring robust governance practices[51]. - The board is tasked with setting strategic goals and ensuring the company has the necessary financial and human resources to achieve them[59]. Risk Management and Compliance - The company has established a corporate risk management framework to identify major risks, including financial, operational, compliance, and IT risks, with regular reviews by the audit committee and the board[94]. - The external auditor found no significant violations or internal control deficiencies during the statutory audit process, indicating effective internal controls[95]. - The board and audit committee believe that the risk management and internal control systems are effective and sufficient to address financial, operational, and compliance risks in the current operating environment[96]. - The company has procedures in place for handling and disclosing insider information, emphasizing the importance of confidentiality and compliance with regulations[96]. Diversity and Employment Practices - The company has achieved a balanced workforce with female employees constituting 52% of the total workforce, including significant representation in corporate positions[80]. - The company emphasizes fair employment practices and diversity in recruitment and promotion processes[80]. - The Board's diversity policy aims to enhance performance quality by considering factors such as gender, age, cultural background, and professional experience[80]. - The company has adopted measurable goals for its diversity policy, focusing on maintaining the current level of female representation on the Board[81]. Financial Position and Assets - Total assets as of December 31, 2024, amounted to HKD 373,742,000, an increase from HKD 318,631,000 in 2023[178]. - Current liabilities increased to HKD 250,607,000 in 2024 from HKD 153,428,000 in 2023, indicating a rise in short-term obligations[178]. - The net asset value as of December 31, 2024, was HKD 164,117,000, slightly down from HKD 165,329,000 in 2023[178]. - The company’s cash and cash equivalents decreased to HKD 66,063,000 in 2024 from HKD 120,618,000 in 2023, reflecting a tighter liquidity position[178]. Shareholder Communication and Dividends - The company has established a shareholder communication policy to facilitate effective communication with shareholders and stakeholders[110]. - The board adopted a dividend policy on March 4, 2019, aimed at providing stable and continuous returns to shareholders[114]. - The group did not declare any interim dividends for the fiscal year ending December 31, 2024, consistent with the previous year[121]. - The board does not recommend a final dividend for the fiscal year ending December 31, 2024, mirroring the decision made in 2023[123].

Financial Performance - For the year ended December 31, 2024, the total revenue increased to HKD 576,615,000, representing a growth of 68.7% compared to HKD 341,863,000 in 2023[4] - The gross profit for the same period was HKD 29,895,000, up from HKD 10,083,000 in 2023, indicating a significant improvement in profitability[4] - The company reported a profit attributable to equity holders of HKD 491,000, a turnaround from a loss of HKD 4,970,000 in the previous year[4] - Total revenue for the year ended December 31, 2024, was HKD 576,615,000, representing a 68.7% increase from HKD 341,863,000 in 2023[18] - The company reported a pre-tax profit of HKD 491,000 for 2024, a significant recovery from a loss of HKD 4,970,000 in 2023[27] - The company achieved a profit of HKD 0.5 million in fiscal year 2024, recovering from a net loss of HKD 5 million in fiscal year 2023[49] Revenue Breakdown - The distribution business segment generated revenue of HKD 52,085,000, while the supply chain business segment contributed HKD 524,530,000, highlighting the latter's dominance in overall revenue[13] - Revenue from the supply chain business was HKD 524,530,000, accounting for 91% of total revenue, while distribution business revenue was HKD 52,085,000[19] - Revenue from China (including Hong Kong and Macau) reached HKD 367,196,000, up 32.5% from HKD 277,166,000 in 2023[19] - The company reported a significant increase in revenue from Asia (excluding China) to HKD 175,514,000, compared to HKD 61,819,000 in 2023[19] - Supply chain business revenue increased by 84.3% to HKD 524.5 million in fiscal year 2024, up from HKD 284.6 million in fiscal year 2023[39] Assets and Liabilities - The total assets as of December 31, 2024, were HKD 373,742,000, compared to HKD 318,631,000 in 2023, reflecting a growth of 17.3%[5] - The net current assets decreased to HKD 123,135,000 from HKD 165,203,000, indicating a decline of 25.5%[5] - The company’s total equity as of December 31, 2024, was HKD 164,117,000, slightly down from HKD 165,329,000 in 2023[5] - Trade receivables increased to HKD 141,709,000 in 2024, compared to HKD 93,102,000 in 2023, indicating improved collection efficiency[29] - Inventory as of December 31, 2024, was HKD 72.4 million, an increase of HKD 31.8 million from HKD 40.6 million on December 31, 2023[50] - Trade payables rose to HKD 55.5 million as of December 31, 2024, an increase of HKD 25.7 million from HKD 29.8 million on December 31, 2023[52] Expenses and Costs - The financing costs decreased to HKD 3,133,000 from HKD 4,059,000, showing a reduction of 22.8%[4] - Sales and distribution expenses increased by 365.7% to HKD 4.2 million in fiscal year 2024, primarily due to increased sales activities[46] - Administrative expenses decreased by 5.2% to HKD 13.0 million in fiscal year 2024, mainly due to reduced legal and professional fees[47] Future Plans and Strategies - The company plans to expand its distribution business in Southwest China, aiming for increased sales contracts by 2025[59] - The company intends to develop long-term supply agreements in coal and traditional Chinese medicine products, targeting stable large-scale trade by 2025[61] - The company aims to expand its business team in the next 12 months to meet growing market demands[63] - The company is actively exploring green energy project investments in Yunnan Province and Southeast Asia, aiming to expand installed capacity and enhance revenue and profit contributions[64] - By 2025, the company plans to deepen its market presence in Southeast Asia, focusing on green energy project investments in Laos and Myanmar[65] - The company aims to leverage its parent company's overseas network to expand its supply chain business in South Asia and Southeast Asia by 2025[65] Corporate Governance and Compliance - The company has not yet applied new or revised international financial reporting standards that have been issued but not yet effective, indicating a potential future impact on financial reporting[11] - The audit committee has reviewed the group's financial performance and has no objections to the accounting principles adopted[74] - The company has not engaged in any buybacks or sales of its listed securities during the fiscal year 2024[73] Dividend Policy - The company did not recommend a final dividend for the year ended December 31, 2024, consistent with 2023[25] - The board does not recommend the payment of a final dividend for the fiscal year ending December 31, 2024[69]

Financial Performance - Revenue for the first half of 2024 reached HKD 218,810 thousand, a 105.4% increase compared to HKD 106,779 thousand in the first half of 2023[66]. - The overall revenue for the first half of 2024 was HKD 218.8 million, an increase of 104.9% from HKD 106.8 million in the first half of 2023[23]. - The company reported a loss before tax of HKD 313 thousand for the first half of 2024, a substantial improvement from a loss of HKD 5,525 thousand in the first half of 2023[66]. - Total comprehensive loss for the first half of 2024 was HKD 974 thousand, compared to HKD 7,966 thousand in the first half of 2023, indicating a reduction in overall losses[68]. - The company’s total equity as of June 30, 2024, was HKD 164,355 thousand, a slight decrease from HKD 165,329 thousand at the end of 2023[69]. Distribution Business - Revenue from the distribution business decreased by 81.1% from HKD 16.4 million in the first half of 2023 to HKD 3.1 million in the first half of 2024, primarily due to delays in delivery and acceptance of equipment[17]. - The distribution business segment generated revenue of HKD 3.09 million for the six months ended June 30, 2024, compared to HKD 16.37 million in the same period of 2023, indicating a decline of about 81%[81]. - The distribution business primarily serves various companies and institutions, including hospitals, universities, and government agencies, all located in China[15]. - The distribution business model remained unchanged in the first half of 2024, focusing on identifying customer needs and providing after-sales services[15]. Supply Chain Business - The supply chain business continued to expand, focusing on construction materials, agricultural and metal products, and medical devices, enhancing revenue sources and profitability[18]. - In the first half of 2024, the company's supply chain business achieved revenue of HKD 215.7 million, a significant increase of 138.6% from HKD 90.4 million in the same period of 2023[22]. - The supply chain business segment reported revenue of HKD 215.72 million for the six months ended June 30, 2024, up from HKD 90.41 million in the prior year, reflecting an increase of approximately 138%[81]. - The supply chain business aims to establish long-term supply agreements in coal and mineral products, while also exploring new international trade opportunities[48]. Inventory and Receivables - Inventory as of June 30, 2024, was HKD 51.4 million, up from HKD 40.6 million at the end of 2023, due to an expanded range of products in the supply chain business[36]. - Trade receivables increased to HKD 162.8 million as of June 30, 2024, from HKD 93.1 million at the end of 2023, driven by increased revenues from agricultural and stainless steel products[36]. - Trade receivables as of June 30, 2024, amounted to HKD 162,807,000, up from HKD 93,102,000 at the end of 2023, reflecting a 74.8% increase[98]. Cash Flow and Current Assets - Cash flow from operating activities for the first half of 2024 was a net outflow of HKD 114,499 thousand, slightly improved from HKD 116,668 thousand in the same period of 2023[75]. - Current assets increased to HKD 368,044 thousand as of June 30, 2024, up from HKD 318,631 thousand at the end of 2023[69]. - Current liabilities rose to HKD 243,821 thousand as of June 30, 2024, compared to HKD 153,428 thousand at the end of 2023[69]. Debt and Liabilities - The capital debt ratio increased significantly to 93.8% as of June 30, 2024, from 55.3% at the end of 2023, reflecting a higher level of debt relative to equity[39]. - Loans from a related company amounted to RMB 140,616,000 (approximately HKD 154,127,000) as of June 30, 2024, with an interest rate of 2.5%[115]. - The group has no significant contingent liabilities as of June 30, 2024, and December 31, 2023[112]. Management and Strategy - The management team for the supply chain business consists of 11 experienced members, led by Mr. Ma, who has over 20 years of international trade experience[48]. - The company is exploring investment opportunities in green energy projects in Yunnan Province and Southeast Asia, aiming to expand energy capacity and improve profitability[50]. - The company plans to increase investments in green energy projects in Yunnan in the second half of 2024, including centralized and decentralized solar and wind energy projects[50]. Shareholding and Dividends - As of June 30, 2024, Baodi International Investment Limited holds a direct interest of 201,196,995 shares, representing approximately 73.05% of the company's issued share capital[56]. - The group did not declare any interim dividends for the first half of 2024, consistent with the same period in 2023[94]. Audit and Compliance - The audit committee has reviewed the unaudited interim results for the first half of 2024 and found no objections to the accounting principles and practices adopted by the company[60]. - The company adopted revised International Financial Reporting Standards, which did not have a significant impact on its financial position or performance[79].

Financial Performance - Revenue for the six months ended June 30, 2024, was HKD 218,810,000, representing a 105.5% increase compared to HKD 106,779,000 for the same period in 2023[2] - Gross profit for the same period was HKD 6,189,000, up from HKD 1,796,000, indicating a significant improvement in profitability[2] - The company reported a loss before tax of HKD 313,000 for the first half of 2024, a substantial reduction from a loss of HKD 5,525,000 in the first half of 2023[2] - Total comprehensive loss for the period was HKD 974,000, compared to HKD 7,966,000 in the previous year, showing a marked decrease in overall losses[3] - The group's pre-tax loss for the six months ended June 30, 2024, was HKD 313,000, significantly improved from a loss of HKD 5,525,000 in the same period of 2023[11] - The company reported a loss of HKD 0.3 million for the first half of 2024, a significant improvement from a loss of HKD 5.9 million in the same period of 2023, attributed to increased demand and effective cost control[49] Revenue Breakdown - Distribution business segment revenue for the six months ended June 30, 2024, was HKD 3,094,000, a decrease from HKD 16,367,000 in the same period of 2023, representing an 81.1% decline[11] - Supply chain business segment revenue for the six months ended June 30, 2024, was HKD 215,716,000, an increase from HKD 90,412,000 in the same period of 2023, representing a 138.8% growth[11] - Revenue from customers located in China (including Hong Kong and Macau) was HKD 161,229,000 for the six months ended June 30, 2024, up from HKD 79,838,000 in the same period of 2023, representing a 102.2% increase[13] - The group had a total of HKD 19,921,000 in recognized revenue from sales of goods for the six months ended June 30, 2024, compared to HKD 11,509,000 in the same period of 2023[17] - Revenue for the first half of 2024 increased by 104.9% to HKD 218.8 million, compared to HKD 106.8 million in the same period of 2023, primarily driven by the supply chain business[40] Assets and Liabilities - Current assets increased to HKD 368,044,000 as of June 30, 2024, compared to HKD 318,631,000 at the end of 2023, reflecting improved liquidity[4] - Trade receivables rose significantly to HKD 162,807,000 from HKD 93,102,000, indicating growth in sales and collection efficiency[4] - Inventory levels increased to HKD 51,410,000 from HKD 40,614,000, suggesting a strategic buildup in stock to meet anticipated demand[4] - The company’s net assets as of June 30, 2024, were HKD 164,355,000, slightly down from HKD 165,329,000 at the end of 2023[5] - The group’s trade payables increased to HKD 53,030,000 as of June 30, 2024, from HKD 29,823,000 as of December 31, 2023, marking a 77.5% increase[31] Operational Highlights - The company continues to engage in distribution of brand analysis and laboratory instruments, as well as supply chain operations for industrial and consumer products[6] - The distribution business faced delays in delivery due to long production and import customs clearance times, impacting revenue recognition in the first half of 2024[35] - The company established stable business relationships with several top-tier hospitals and medical equipment distributors in Yunnan Province, leading to multiple procurement contracts[35] - The supply chain business sold approximately 1,398.6 tons of stainless steel raw materials and 6 sets of stainless steel production equipment in the first half of 2024[38] - The company continues to leverage its extensive customer base and management experience in the international supply chain sector to optimize trade chains and reduce risks[37] Future Plans and Investments - The group plans to expand its distribution business in Southwest China, leveraging resources from Yunnan Energy Investment Group to increase revenue and profit contributions[61] - The group aims to actively participate in public tenders for medical equipment in major hospitals in Southwest China, targeting new project collaborations to enhance sales performance[61] - The supply chain business will focus on signing long-term supply agreements in coal and mineral products, while also exploring new customers in international trade[63] - The group plans to expand investment opportunities in green energy projects in Yunnan Province and Southeast Asia in the second half of 2024[65] Employee and Governance - As of June 30, 2024, the total installed capacity of six solar photovoltaic power stations in Dayaoshan is approximately 523,000 kW, with commercial operations expected to start in Q3 2024[65] - The group is committed to enhancing employee training and capabilities to meet the growing business activities and market demands[64] - The group did not declare any interim dividend for the six months ended June 30, 2024, consistent with the previous year[23] - The company has adhered to the applicable provisions of the Hong Kong Corporate Governance Code during the first half of 2024[72] - The company has adopted the standard code of conduct for securities trading as per the listing rules, with no violations reported by employees in the first half of 2024[74]